Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 211,574 | 303,227 | 132,527 | 365,639 | 179,009 |
| Marketable Securities | 34,658 | 0 | 15,000 | 71,880 | 154,115 |
| Receivables | 469 | 1,050 | 13,500 | 5,163 | 14,815 |
| Inventories | N/A | N/A | N/A | N/A | 19,663 |
| Income taxes - deferred | 19,902 | 1,271 | 17,996 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 270,400 | 0 |
| TOTAL | $284,663 | $315,836 | $180,681 | $720,434 | $379,496 |
| Non-Current Assets | |||||
| PPE Net | 80 | 171 | 1,123 | 330,746 | 296,529 |
| Investments And Advances | 1,997 | 0 | 0 | 3,269 | 74,892 |
| Intangibles | 0 | 0 | 0 | 90,780 | 355,667 |
| Other Non-Current Assets | 29,926 | 22,404 | 9,338 | 46,963 | 35,309 |
| TOTAL | $32,003 | $22,575 | $10,461 | $471,758 | $762,397 |
| Total Assets | $316,666 | $338,411 | $191,142 | $1,192,192 | $1,141,893 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 678 | 1,239 |
| Accounts payable and accrued liabilities | 2,540 | 370 | 1,717 | 8,893 | 13,478 |
| Accrued Expenses | 184,247 | 77,852 | 12,290 | 33,189 | 25,903 |
| TOTAL | $193,991 | $293,516 | $31,513 | $122,088 | $106,063 |
| Non-Current Liabilities | |||||
| Long Term Debt | 85,023 | 222,148 | N/A | N/A | 36,925 |
| Deferred Revenues | N/A | 1,600 | 100 | 7,171 | 13,443 |
| Other Non-Current Liabilities | 361,834 | 238,700 | 510,698 | 534,847 | 499,998 |
| TOTAL | $446,857 | $460,848 | $512,198 | $562,494 | $568,289 |
| Total Liabilities | $640,848 | $754,364 | $543,711 | $684,582 | $674,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,680 | 119,674 | 119,432 | 117,668 | 115,266 |
| Common Shares | 1,396 | 1,195 | 1,193 | 1,176 | 1,150 |
| Retained earnings | -241,424 | -333,298 | -522,958 | -591,345 | -570,129 |
| Other shareholders' equity | 3,219 | 0 | 0 | -472 | -1,326 |
| TOTAL | $-324,182 | $-415,953 | $-352,569 | $507,610 | $467,541 |
| Total Liabilities And Equity | $316,666 | $338,411 | $191,142 | $1,192,192 | $1,141,893 |